Resultados de la búsqueda 511-520 of 70193 for Treatment

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers. Rochester, Minn. The purpose of this study is to determine the response ...

  2. Radiología - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...

  3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment. Scottsdale/Phoenix, Ariz. The purpose of this study is to identify subtype- ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Radiation is typically given in 6-7 weeks for head and neck cancer using X-ray therapy, but this study will administer treatment in approximately 3 weeks. To ...

  7. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    A Study to Promote Shared Decision Making of Treatment Choices in Patients who have Advanced Kidney Disease. Rochester, Minn., Scottsdale/Phoenix, Ariz ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...